Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia

Clin Lab Haematol. 2005 Feb;27(1):79-80. doi: 10.1111/j.1365-2257.2004.00657.x.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Benzamides
  • Flow Cytometry
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Neutrophils / drug effects*
  • Neutrophils / metabolism*
  • Oxygen Consumption / drug effects
  • Piperazines / pharmacology*
  • Pyrimidines / pharmacology*
  • Respiratory Burst / drug effects*

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate